Effectiveness and safety of low-dose versus standard-dose rivaroxaban and apixaban in patients with atrial fibrillation

BACKGROUND: Low-dose direct oral anticoagulant (DOAC) use is quite prevalent in clinical practice, but evidence of its effectiveness and safety compared with high-dose DOAC in patients with atrial fibrillation (AF) remains limited. We aimed to assess the effectiveness and safety of low-dose and high...

Descripción completa

Detalles Bibliográficos
Autores principales: Perreault, Sylvie, Côté, Robert, Dragomir, Alice, White-Guay, Brian, Lenglet, Aurélie, Dorais, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714756/
https://www.ncbi.nlm.nih.gov/pubmed/36454798
http://dx.doi.org/10.1371/journal.pone.0277744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714756/
https://www.ncbi.nlm.nih.gov/pubmed/36454798
http://dx.doi.org/10.1371/journal.pone.0277744

Ejemplares similares